Decoy Therapeutics Accelerates Path to Clinical Development in Antiviral Innovations Decoy Therapeutics is navigating an active phase, charting its clinical development in antiviral treatments. Key achievements and future plans highlight its rapid momentum.

Decoy Therapeutics Accelerates Path to Clinical Development in Antiviral Innovations #United_States #Cambridge #Decoy_Therapeutics #D-MAVs #IMP³ACT